Drug Type CAR-T |
Synonyms CD19-CAR-mbIL15-DNT Cells(Ruishun Biotech), RS-001(Ruishun Biotech) |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
High grade B-cell lymphoma | Phase 1 | - | 01 Apr 2025 | |
Mediastinal large B-cell lymphoma | Phase 1 | - | 01 Apr 2025 | |
Philadelphia positive acute lymphocytic leukaemia | Phase 1 | - | 01 Apr 2025 | |
Pre B-cell acute lymphoblastic leukemia | Phase 1 | - | 01 Apr 2025 |